WO2000043791A3 - Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases - Google Patents

Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases Download PDF

Info

Publication number
WO2000043791A3
WO2000043791A3 PCT/US2000/001997 US0001997W WO0043791A3 WO 2000043791 A3 WO2000043791 A3 WO 2000043791A3 US 0001997 W US0001997 W US 0001997W WO 0043791 A3 WO0043791 A3 WO 0043791A3
Authority
WO
WIPO (PCT)
Prior art keywords
rapid
species
neurodegenerative diseases
sensitive detection
protein aggregation
Prior art date
Application number
PCT/US2000/001997
Other languages
French (fr)
Other versions
WO2000043791A2 (en
WO2000043791A9 (en
Inventor
Cynthia Carol Bamdad
R Shoshana Bamdad
Original Assignee
Minerva Biotechnologies Corp
Cynthia Carol Bamdad
R Shoshana Bamdad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Biotechnologies Corp, Cynthia Carol Bamdad, R Shoshana Bamdad filed Critical Minerva Biotechnologies Corp
Priority to CA002361013A priority Critical patent/CA2361013A1/en
Priority to AU34741/00A priority patent/AU3474100A/en
Priority to JP2000595161A priority patent/JP5122705B2/en
Priority to EP00913266A priority patent/EP1169646A2/en
Publication of WO2000043791A2 publication Critical patent/WO2000043791A2/en
Publication of WO2000043791A3 publication Critical patent/WO2000043791A3/en
Publication of WO2000043791A9 publication Critical patent/WO2000043791A9/en
Priority to US10/823,097 priority patent/US20050112607A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Abstract

Methods, assays, and components are described in which biological samples can be rapidly and sensitively analyzed for the presence of species associated with neurodegenerative disease. Techniques and components are provided for diagnosis of disease, as well as for screening of candidate drugs for treatment of neurodegenerative disease. The techniques are simple, extremely sensitive, and utilize readily-available components. Binding species, capable of binding a neurodegenerative disease aggregate-forming or fibril-forming species, are fastened to surfaces of electrodes and surfaces of particles, or provided free in solution, to bind fibril-forming species and/or be involved in aggregation.
PCT/US2000/001997 1999-01-23 2000-01-25 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases WO2000043791A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002361013A CA2361013A1 (en) 1999-01-25 2000-01-25 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
AU34741/00A AU3474100A (en) 1999-01-25 2000-01-25 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
JP2000595161A JP5122705B2 (en) 1999-01-25 2000-01-25 Rapid and sensitive detection of abnormal protein aggregation in neurodegenerative diseases
EP00913266A EP1169646A2 (en) 1999-01-25 2000-01-25 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
US10/823,097 US20050112607A1 (en) 1999-01-23 2004-04-13 Rapid and sensitive detection of protein aggregation

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11712699P 1999-01-25 1999-01-25
US60/117,126 1999-01-25
US13228899P 1999-05-03 1999-05-03
US60/132,288 1999-05-03
US15593799P 1999-09-24 1999-09-24
US60/155,937 1999-09-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US60268900A Continuation-In-Part 1999-01-23 2000-06-23

Publications (3)

Publication Number Publication Date
WO2000043791A2 WO2000043791A2 (en) 2000-07-27
WO2000043791A3 true WO2000043791A3 (en) 2001-07-26
WO2000043791A9 WO2000043791A9 (en) 2002-03-28

Family

ID=27381935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/001997 WO2000043791A2 (en) 1999-01-23 2000-01-25 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases

Country Status (5)

Country Link
EP (1) EP1169646A2 (en)
JP (2) JP5122705B2 (en)
AU (1) AU3474100A (en)
CA (1) CA2361013A1 (en)
WO (1) WO2000043791A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1356296B1 (en) * 2000-06-23 2016-04-20 Minerva Biotechnologies Corporation Rapid and sensitive detection of protein aggregation
WO2002029411A2 (en) 2000-10-03 2002-04-11 Minerva Biotechnologies Corporation Magnetic in situ dilution
AU2002219971A1 (en) 2000-11-01 2002-05-15 Minerva Biotechnologies Corporation Detection of binding species with colloidal and non-colloidal structures
WO2002061129A2 (en) 2000-11-15 2002-08-08 Minerva Biotechnologies Corporation Oligonucleotide identifiers
WO2002056022A2 (en) 2000-11-27 2002-07-18 Minerva Biotechnologies Corp Diagnostics, drug screening and treatment for cancer
US20030044843A1 (en) * 2001-01-09 2003-03-06 Mitsubishi Pharma Corporation Novel proteome analysis method and devices therefor
EP1395833B1 (en) 2001-05-31 2013-02-27 Adlyfe, Inc. Misfolded protein sensor method
US20050026165A1 (en) 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
EP1425016B1 (en) 2001-09-05 2010-06-02 Minerva Biotechnologies Corporation Compositions and methods of treatment of cancer
AU2003272924B2 (en) 2002-10-04 2008-05-15 Protosera Inc. Plate for mass spectrometry, process for preparing the same and use thereof
EP2363410B1 (en) 2002-11-27 2017-10-11 Minerva Biotechnologies Corporation Isoforms of MUC1
AU2003300371A1 (en) 2002-12-20 2004-07-22 Minerva Biotechnologies Corporation Optical devices and methods involving nanoparticles
WO2005016127A2 (en) 2003-08-13 2005-02-24 Chiron Corporation Prion-specific peptide reagents
ATE442588T1 (en) 2004-03-31 2009-09-15 Anges Mg Inc TEST METHOD FOR IDENTIFYING A CANDIDATE DRUG
DE102004040119A1 (en) * 2004-08-18 2006-04-27 Heinrich-Heine-Universität Düsseldorf Agent, useful for e.g. inactivating infectious prion and decontaminating device, instrument or appliance infected with prion, comprises a nano-particle
NZ560535A (en) * 2005-01-13 2011-01-28 Novartis Vaccines & Diagnostic Elisa assays using prion-specific peptide reagents
ATE528649T1 (en) * 2005-02-15 2011-10-15 Adlyfe Inc METHOD FOR DETECTING MISFOLDED PROTEINS AND PRIONS
NZ566020A (en) 2005-09-09 2012-08-31 Novartis Ag Prion-specific peptoid reagents
EP2156181B1 (en) 2006-07-28 2015-11-04 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
KR20170110740A (en) 2008-10-09 2017-10-11 미네르바 바이오테크놀로지 코포레이션 Method for inducing pluripotency in cells
WO2012017739A1 (en) * 2010-07-31 2012-02-09 エレコン科学株式会社 Amyloid assay device and amyloid assay method
KR101352849B1 (en) * 2012-01-03 2014-01-21 주식회사 나노엔텍 Method for Differentially Detecting Multimeric Form of Multimer-Forming Polypeptides
JP2016520846A (en) * 2013-06-06 2016-07-14 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． Reagents, methods and apparatus for preventing aggregation in particle-based tests for detection of multimeric target molecules
EP3256494A4 (en) 2015-02-10 2018-12-05 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies
JP6630972B2 (en) * 2015-03-24 2020-01-15 学校法人甲南学園 Biosensor for electrochemical measurement of amyloid β peptide
WO2017138696A1 (en) * 2016-02-12 2017-08-17 주식회사 캔티스 Detection method and electrochemical detection kit for aggregate form of protein, and diagnostic method and electrochemical diagnostic kit for diseases associated with abnormal protein aggregation by using same
US11167283B2 (en) 2018-05-04 2021-11-09 University Of South Carolina Dot blot box and use thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945045A (en) * 1984-07-06 1990-07-31 Serono Diagnostics Ltd. Electrochemical methods of assay
WO1994009364A1 (en) * 1992-10-13 1994-04-28 Duke University Method of inhibiting binding of amyloid precursor protein to beta-amyloid protein
WO1994010569A1 (en) * 1992-10-26 1994-05-11 Schenk Dale B METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE
WO1994013795A1 (en) * 1992-12-14 1994-06-23 N.V. Innogenetics S.A. Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
EP0683234A1 (en) * 1993-01-25 1995-11-22 Takeda Chemical Industries, Ltd. ANTIBODY AGAINST $g(b)-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF
WO1997010505A1 (en) * 1995-09-14 1997-03-20 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿
WO1998031839A2 (en) * 1997-01-21 1998-07-23 President And Fellows Of Harvard College Electronic-property probing of biological molecules at surfaces
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
EP0887645A1 (en) * 1997-06-23 1998-12-30 C.S.E.M. Centre Suisse D'electronique Et De Microtechnique Sa Procedure and instrumentation for the ultrasensitive detection of prions, prion binding biomolecules and other biomolecules

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705402A (en) * 1988-11-03 1998-01-06 Igen International, Inc. Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
GB9105031D0 (en) * 1991-03-09 1991-04-24 Fisons Plc Processing analytical reagents
TW239881B (en) * 1992-12-22 1995-02-01 Sienna Biotech Inc
JPH06289020A (en) * 1993-04-06 1994-10-18 Teijin Ltd Method for measuring protein derived from alveolar bone
DE4430023A1 (en) * 1994-08-24 1996-02-29 Boehringer Mannheim Gmbh Electrochemical sensor
SE9403245D0 (en) * 1994-09-26 1994-09-26 Pharmacia Biosensor Ab Improvements relating to bilayer lipid membranes
US6207369B1 (en) * 1995-03-10 2001-03-27 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
JPH09275214A (en) * 1996-04-08 1997-10-21 Hitachi Ltd Very-small charge controlling device and manufacture thereof
WO1998029727A2 (en) * 1996-12-31 1998-07-09 Stephon, Robert, L. Microsphere-enhanced immunoassay for the detection of veterinary diseases
JPH10204350A (en) * 1997-01-27 1998-08-04 Seiko Epson Corp Ink, ink-jet head, printer, and wiring board
JPH10217457A (en) * 1997-02-04 1998-08-18 Seiko Epson Corp Ink jet head and manufacture thereof
EP0865078A1 (en) * 1997-03-13 1998-09-16 Hitachi Europe Limited Method of depositing nanometre scale particles
US5998224A (en) * 1997-05-16 1999-12-07 Abbott Laboratories Magnetically assisted binding assays utilizing a magnetically responsive reagent
SG75126A1 (en) 1997-06-23 2000-09-19 Gen Electric Electrochemical sensor for detection of chlorine in phosgene

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945045A (en) * 1984-07-06 1990-07-31 Serono Diagnostics Ltd. Electrochemical methods of assay
WO1994009364A1 (en) * 1992-10-13 1994-04-28 Duke University Method of inhibiting binding of amyloid precursor protein to beta-amyloid protein
WO1994010569A1 (en) * 1992-10-26 1994-05-11 Schenk Dale B METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE
WO1994013795A1 (en) * 1992-12-14 1994-06-23 N.V. Innogenetics S.A. Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
EP0683234A1 (en) * 1993-01-25 1995-11-22 Takeda Chemical Industries, Ltd. ANTIBODY AGAINST $g(b)-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF
WO1997010505A1 (en) * 1995-09-14 1997-03-20 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿
WO1998031839A2 (en) * 1997-01-21 1998-07-23 President And Fellows Of Harvard College Electronic-property probing of biological molecules at surfaces
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
EP0887645A1 (en) * 1997-06-23 1998-12-30 C.S.E.M. Centre Suisse D'electronique Et De Microtechnique Sa Procedure and instrumentation for the ultrasensitive detection of prions, prion binding biomolecules and other biomolecules

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BANDYOPADHYAY, KRISANU ET AL: "Effect of co-adsorbed surfactant on the structure of self-assembled monolayer of thiol on polycrystalline gold", J. COLLOID INTERFACE SCI. (1998), 206(1), 224-230, XP002159016 *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; LIU, JIAN ET AL: "Preparation of self-assembled monolayer from micellar solutions", XP002159019, retrieved from STN Database accession no. 128:197112 *
FAN, HONGYOU ET AL: "Adsorption of Surface-Modified Colloidal Gold Particles onto Self - Assembled Monolayers: A Model System for the Study of Interactions of Colloidal Particles and Organic Surfaces", LANGMUIR (1997), 13(2), 119-121, XP002159017 *
ISR. J. CHEM. (1997), 37(2-3), 235-239 *
MAYYA, K. S. ET AL: "Lamellar multilayer gold cluster films deposited by the Langmuir-Blodgett technique", LANGMUIR (1997), 13(9), 2575-2577, XP002159018 *
See also references of EP1169646A2 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9096652B2 (en) 2008-05-13 2015-08-04 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Also Published As

Publication number Publication date
WO2000043791A2 (en) 2000-07-27
CA2361013A1 (en) 2000-07-27
AU3474100A (en) 2000-08-07
EP1169646A2 (en) 2002-01-09
JP2002540383A (en) 2002-11-26
WO2000043791A9 (en) 2002-03-28
JP2012230124A (en) 2012-11-22
JP5122705B2 (en) 2013-01-16

Similar Documents

Publication Publication Date Title
WO2000043791A3 (en) Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
WO2002061129A3 (en) Oligonucleotide identifiers
WO2002001230A3 (en) Rapid and sensitive detection of protein aggregation
SI1668368T1 (en) Detection of histone modification in cell-free nucleosomes
NO996243L (en) Retentate chromatography and protein chip series with applications in biology and medicine
DE60136335D1 (en) PARALLEL GENOTYPING OF SEVERAL PATIENT SAMPLES
DK1098658T3 (en) Manipulated proteins for detecting analytes
WO2004061084A3 (en) Modulation of protein functionalities
ATE408841T1 (en) ASSAY FOR DETECTION OF GLYCATED OR GLYCOSYLATED HEMOGLOBIN (HBA1C)
ATE222254T1 (en) USE OF A METALLOPORPHYRIN CONJUGATE FOR DETECTING BIOLOGICAL COMPOUNDS
BRPI0518994A2 (en) br3-binding antibodies or polypeptides, their uses and liquid formulations
WO2006124644A3 (en) Protein and antibody profiling using small molecule microarrays
EP2330219A3 (en) Method for drug discovery, disease treatment and diagnosis using metabolomics
WO1998035232A3 (en) Electrochemical detection of specific binding
BRPI0610092B8 (en) methods for detecting an analyte and nucleic acid in a sample, and synthesizing a nucleic acid or nucleic acid analogue molecule, reagent kit, use thereof, nucleic acid or nucleic acid analogue molecule, and associated product
WO2004094647A3 (en) Methods of treating diseases responsive to induction of apoptosis and screening assays
WO2002063271A3 (en) Activity based probe analysis
WO2007067983A3 (en) Sulfotyrosine specific antibodies and uses therefor
EP2211176A3 (en) Analyzing nerve cell damage
PL376121A1 (en) Diagnostic set for the examination of animal serum for presence of rhd antibodies and diagnostic set for detection of the rhd virus
WO2000023615A3 (en) Method for extracting quantitative information relating to an influence on a cellular response
IT8921788A0 (en) REAGENT USEFUL FOR THE DETECTION AND QUANTITATIVE DETERMINATION OF LEUKOCYTES IN BIOLOGICAL FLUIDS.
WO2004010143A3 (en) Electrochemical lateral flow and flow-through devices
WO2002016947A3 (en) Methods and kits for separation and detection of proteins in biological samples
WO2004113574A3 (en) Methods for disease screening

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 34741/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2361013

Country of ref document: CA

Ref country code: CA

Ref document number: 2361013

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 595161

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000913266

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000913266

Country of ref document: EP

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/11-11/11, DRAWINGS, REPLACED BY NEW PAGES 1/11-11/11; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE